Year |
Citation |
Score |
2022 |
Njikan S, Ahmed S, Manning A, Awasthi D, Ovechkina Y, Chowdhury S, Butts A, Parish T. Chemical Exploration of a Highly Selective Scaffold with Activity against Intracellular . Microbiology Spectrum. e0116122. PMID 35612308 DOI: 10.1128/spectrum.01161-22 |
0.362 |
|
2019 |
Butts A, Reitler P, Nishimoto AT, DeJarnette C, Estredge LR, Peters TL, Veve MP, Rogers PD, Palmer GE. A systematic screen reveals a diverse collection of medications induce antifungal resistance in species. Antimicrobial Agents and Chemotherapy. PMID 30858206 DOI: 10.1128/Aac.00054-19 |
0.49 |
|
2018 |
Luna-Tapia A, Butts A, Palmer GE. Loss of C-5 sterol desaturase activity in - azole resistance or merely trailing growth? Antimicrobial Agents and Chemotherapy. PMID 30323044 DOI: 10.1128/Aac.01337-18 |
0.302 |
|
2018 |
Butts A, Reitler P, Ge W, Fortwendel JR, Palmer GE. Commonly used oncology drugs decrease antifungal effectiveness against and species. Antimicrobial Agents and Chemotherapy. PMID 29712657 DOI: 10.1128/Aac.00504-18 |
0.507 |
|
2017 |
Butts A, DeJarnette C, Peters TL, Parker JE, Kerns ME, Eberle KE, Kelly SL, Palmer GE. Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes. Msphere. 2. PMID 28989971 DOI: 10.1128/mSphere.00379-17 |
0.302 |
|
2016 |
Butts A, Palmer GE, Rogers PD. Antifungal adjuvants: preserving and extending the antifungal arsenal. Virulence. 0. PMID 27459018 DOI: 10.1080/21505594.2016.1216283 |
0.448 |
|
2015 |
Butts A, Martin JA, DiDone L, Bradley EK, Mutz M, Krysan DJ. Structure-activity relationships for the antifungal activity of selective estrogen receptor antagonists related to tamoxifen. Plos One. 10: e0125927. PMID 26016941 DOI: 10.1371/Journal.Pone.0125927 |
0.553 |
|
2014 |
Brown JC, Nelson J, VanderSluis B, Deshpande R, Butts A, Kagan S, Polacheck I, Krysan DJ, Myers CL, Madhani HD. Unraveling the biology of a fungal meningitis pathogen using chemical genetics. Cell. 159: 1168-87. PMID 25416953 DOI: 10.1016/J.Cell.2014.10.044 |
0.539 |
|
2014 |
Butts A, Koselny K, Chabrier-Roselló Y, Semighini CP, Brown JC, Wang X, Annadurai S, DiDone L, Tabroff J, Childers WE, Abou-Gharbia M, Wellington M, Cardenas ME, Madhani HD, Heitman J, et al. Estrogen receptor antagonists are anti-cryptococcal agents that directly bind EF hand proteins and synergize with fluconazole in vivo. Mbio. 5: e00765-13. PMID 24520056 DOI: 10.1128/Mbio.00765-13 |
0.602 |
|
2013 |
Butts A, DiDone L, Koselny K, Baxter BK, Chabrier-Rosello Y, Wellington M, Krysan DJ. A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis. Eukaryotic Cell. 12: 278-87. PMID 23243064 DOI: 10.1128/Ec.00314-12 |
0.599 |
|
2012 |
Butts A, Krysan DJ. Antifungal drug discovery: something old and something new. Plos Pathogens. 8: e1002870. PMID 22969422 DOI: 10.1371/Journal.Ppat.1002870 |
0.555 |
|
Show low-probability matches. |